IL6 and myeloid sarcoma: Furthermore, the inflammatory environment in MS, characterized by elevated pro-inflammatory cytokines and oxidative stress, may also contribute to the inhibition of GPx activity [19] but also in this case we did not find significant correlation between GPx activity and IL-6 concentration.